Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type

ClinicalTrials.gov ID: NCT01922258

Public ClinicalTrials.gov record NCT01922258. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 5:12 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Flexible Dosing of Brexpiprazole (OPC-34712) in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To compare the efficacy of flexible dosing of brexpiprazole with placebo in subjects with agitation associated with dementia of the Alzheimer's type

Study identification

NCT ID
NCT01922258
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
270 participants

Conditions and interventions

Eligibility (public fields only)

Age range
55 Years to 90 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2013 (Actual)
Primary completion
Mar 2017 (Actual)
Completion
Mar 2017 (Actual)
Last update posted
Nov 20, 2020

2013 – 2017

United States locations

U.S. sites
28
U.S. states
12
U.S. cities
24
Facility City State ZIP Site status
Not listed Imperial California 92251 —
Not listed Lakewood California 08755 —
Not listed Long Beach California 90806 —
Not listed Long Beach California 90822 —
Not listed Panorama City California 91402 —
Not listed Universal City California 91950 —
Not listed Denver Colorado 80209 —
Not listed Bradenton Florida 34205 —
Not listed Miami Florida 33142 —
Not listed Miami Florida 33165 —
Not listed Miami Florida 33176 —
Not listed Orange City Florida 32763 —
Not listed Atlanta Georgia 30331 —
Not listed Smyrna Georgia 30080 —
Not listed Honolulu Hawaii 96817 —
Not listed Indianapolis Indiana 46256 —
Not listed Quincy Massachusetts 02169 —
Not listed South Dartmouth Massachusetts 02747 —
Not listed Ann Arbor Michigan 48105 —
Not listed Brooklyn New York 11214 —
Not listed Buffalo New York 14215 —
Not listed New Hyde Park New York 11040 —
Not listed Charlotte North Carolina 28270 —
Not listed Raleigh North Carolina 27609 —
Not listed Austin Texas 78757 —
Not listed Dallas Texas 75231 —
Not listed Dallas Texas 75243 —
Not listed Woodstock Vermont 05091 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 42 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01922258, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 20, 2020 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01922258 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →